alert icon Important Updates + Notice of Vendor Data Event

Coming to a Cleveland Clinic location?
Hillcrest Cancer Center check-in changes
Cole Eye entrance closing
Visitation and COVID-19 information

Notice of MedInform data event
Learn more

Brian Bolwell, MD

Brian Bolwell, MD
  • Watch Video
  • No ratings
  • 0 Patient Satisfaction Ratings
  • 0 Patient Comments
Title Chair, Physician Leadership and Development
Department Professional Staff Affairs
Primary Location Cleveland Clinic Main Campus
Type of Doctor Adults Only
Languages English
Surgeon No
Cleveland Clinic Main Campus
Primary Location

Cleveland Clinic Main Campus

Specialties & Treatments

Treatment & Services

  • Bone Marrow Transplantation
  • Cancer Center
  • Hematology
  • Hematopoietic Stem Cell Transplantation
View all 4 Treatment & Services +

Specialty in Diseases & Conditions

  • Cancer
  • Hematologic Malignancies
  • Hodgkin's Disease
  • Lymphoma
  • Non-Hodgkin's Lymphoma
View all 5 Specialties +


Is Cleveland Clinic Part of Your Insurance?

Review a list of accepted insurance plans for our Northeast Ohio locations or learn more about purchasing a contracted managed care plan.

View All Plans

About Brian Bolwell, MD

Brian Bolwell, MD is Chairman of Physician Leadership and Development at the Cleveland Clinic. He was previously Chairman of the Taussig Cancer Institute from 2011-2021. He was Director of the Cleveland Clinic Bone Marrow Transplant Program for 24 years, and Chairman of the Department of Hematologic Oncology & Blood Disorders from 2006-2011. He has authored over 450 articles and abstracts concerning bone marrow transplantation, lymphoma, and other hematologic malignancies. Dr. Bolwell has edited the textbook “Current Controversies of Bone Marrow Transplantation” (Humana Press, 2000), and is co-editor of the textbook “Clinical Malignant Hematology” (McGraw Hill, 2007). Dr. Bolwell is an ad hoc reviewer for the Journal of Clinical Oncology, Bone Marrow Transplantation, Blood, Annals of Internal Medicine, and many other scientific periodicals. Dr. Bolwell has served as a grant reviewer for the National Cancer Institute on multiple occasions. He has also served on leadership committees for the American Society of Hematology (ASH) and the Center for International Bone Marrow Transplantation Research (CIBMTR). 

Dr. Bolwell is also a Professor of Medicine for Cleveland Clinic Lerner College of Medicine at Case Western Reserve University.

Education & Professional Highlights

Education & Professional Highlights


Education & Fellowships

Fellowship - Hospital of the University of Pennsylvania
Philadelphia, PA USA

Residency - University Hospitals of Cleveland
Internal Medicine
Cleveland, OH USA

Internship - University Hospitals of Cleveland
Internal Medicine
Cleveland, OH USA

Medical Education - Case Western Reserve University School of Medicine
Cleveland, OH USA

Undergraduate - Harvard University
Cambridge, MA USA

Professional Highlights

  • Chairman, Physician Leadership and Development at Cleveland Clinic, 2021=present
  • Chairman, Taussig Cancer Institute, 2011-2021
  • Member, Cleveland Clinic Board of Governors, 2005-2013
  • Chairman, Department of Hematologic Oncology and Blood Disorders, 2006-2011
  • Director, Bone Marrow Transplantation Program, 1988-2011


  • Internal Medicine
  • Internal Medicine - Medical Oncology

Specialty Interests

Bone marrow transplantation (BMT), hematologic malignancies, Hodgkins Disease/lymphoma, non-Hodgkins lymphoma, lymphoma, cancer

Awards & Honors

  • Member, Who’s Who in Medicine and Healthcare (2006-present)
  • Castle Connolly Top Doctors Guide (2007-present)
  • Fellow, American College of Physicians (2009-present)


  • American Society of Hematology
  • American Society of Clinical Oncology
  • American Medical Association
  • American Association for Cancer Research
  • American Society for Blood and Marrow Transplantation
Research & Publications

Research & Publications

See publications for Brian Bolwell, MD.

(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Industry Relationships

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 2/14/2023, Dr. Bolwell has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Back to Top